Adiponectin has anti-angiogenic activity [72], so that high levels in older DS patients [25] might contribute to the risk of Alzheimer’s disease through neuronal blood deprivation. This evidence concerns the gene ADIPOQ and early-onset autosomal dominant Alzheimer disease.